10Y annualized return is
very good
at 12.0% per year
TMO has met or exceeded earnings expectations in
most
recent quarters (9/10)
Reasonable P/E Ratio
Solid Price-to-Sales Ratio
High P/FCF Ratio
Moderate Operating Profit Margin
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Thermo Fisher Scientific demonstrates a strong business quality through consistent revenue growth, innovation, and a solid market position. Future prospects appear positive with robust guidance for 2025 and a strong innovation pipeline, although potential policy changes could introduce some uncertainty.
Analysis Date: January 30, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Thermo Fisher Scientific Inc. is a company that helps scientists and researchers in healthcare and life sciences. They provide tools and products like lab equipment, testing kits, and materials needed to develop medicines and vaccines. Their work supports hospitals, universities, and businesses that need to understand diseases and improve health. Essentially, they make it easier for scientists to do their important work in improving our health and safety.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect TMO's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact TMO's performance.
Access Full Risk AnalysisLatest News
Market fear creates hesitation, but history shows scary headlines often mark great buying opportunities. I assess risk, not just wait for perfect timi...
Get a deeper insight into the potential performance of Thermo Fisher (TMO) for the quarter ended March 2025 by going beyond Wall Street's top -and-bot...
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights